Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants
Clinical trial NCT03169881 · COMPLETED
Trial details
- NCT number
- NCT03169881
- Sponsor
- NICHD Neonatal Research Network
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-20
- Primary completion
- 2022-12-23
- Enrollment
- 650
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.